Novel coronavirus-specific nutralising antibodies last at least for six months
The researchers found that neutralizing antibodies were over 70% even at the end of six months. While IgG showed
Read More
Day: August 15, 2020
SARS-CoV-2-specific T cell immunity prevents recurrent severe COVID-19 disease
The immune system elicits robust, broad and highly functional memory T cell responses once a person is infected with
Read More
Interim results of phase-1-2 trials find inactivated coronavirus vaccine is safe
Interim results of Phase-1 and Phase-2 trials of an inactivated SARS-CoV-2 vaccine carried out in China show that the
Read More